Valve permitting mixing in a drug delivery device

    公开(公告)号:US10195344B2

    公开(公告)日:2019-02-05

    申请号:US14443490

    申请日:2013-11-20

    Abstract: A valve (10) for permitting mixing of at least two components within a barrel (12) is provided including a stopper (20) configured for slidable liquid-tight engagement with an inner surface (13) of the barrel. The stopper is moveable between a first position and a second position and includes a proximal end (22), a distal end (24), and a channel (26) extending therebetween. The valve further includes a stationary body (30) comprising a base (32) and a stem (34), the stem being disposed within the channel of the stopper when the stopper is in the second position. When the stopper is in the first position, there is a liquid-tight seal in the channel, such that fluid flow through the channel is prevented. Movement of the stopper to the second position terminates the liquid-tight seal, thereby establishing fluid communication through the channel. A drug containing device and assembly for delivering a reconstituted drug are also provided herein.

    CONTINUOUS GLUCOSE MONITORING INJECTION DEVICE

    公开(公告)号:US20210402092A1

    公开(公告)日:2021-12-30

    申请号:US17471054

    申请日:2021-09-09

    Abstract: An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

    Needle assembly for mixing of substances

    公开(公告)号:US10434264B2

    公开(公告)日:2019-10-08

    申请号:US15681161

    申请日:2017-08-18

    Abstract: In one aspect of the invention, a needle assembly is provided, including: a body having a proximal end, a distal end, and a channel located therebetween, the body being configured to be mounted to an injector; a needle fixed to the body, the needle having proximal and distal ends, the distal end extending distally from the distal end of the body and being formed for insertion into a patient, the proximal end of the needle being in communication with the channel; and, a filter disposed in the channel proximally of the proximal end of the needle. Advantageously, a needle assembly is provided which permits mixing of at least two substances in preparation for injection, without modification to the associated injector.

    Continuous glucose monitoring injection device

    公开(公告)号:US10252002B2

    公开(公告)日:2019-04-09

    申请号:US15500913

    申请日:2015-07-30

    Abstract: An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

    Valve Permitting Mixing in a Drug Delivery Device
    5.
    发明申请
    Valve Permitting Mixing in a Drug Delivery Device 审中-公开
    药物输送装置中的阀门允许混合

    公开(公告)号:US20150314071A1

    公开(公告)日:2015-11-05

    申请号:US14443490

    申请日:2013-11-20

    Abstract: A valve (10) for permitting mixing of at least two components within a barrel (12) is provided including a stopper (20) configured for slidable liquid-tight engagement with an inner surface (13) of the barrel. The stopper is moveable between a first position and a second position and includes a proximal end (22), a distal end (24), and a channel (26) extending therebetween. The valve further includes a stationary body (30) comprising a base (32) and a stem (34), the stem being disposed within the channel of the stopper when the stopper is in the second position. When the stopper is in the first position, there is a liquid-tight seal in the channel, such that fluid flow through the channel is prevented. Movement of the stopper to the second position terminates the liquid-tight seal, thereby establishing fluid communication through the channel. A drug containing device and assembly for delivering a reconstituted drug are also provided herein.

    Abstract translation: 提供一种用于允许在筒体(12)内混合至少两个部件的阀门(10),其包括被配置为与所述筒体的内表面(13)可滑动地液密接合的止动件(20)。 止动件可在第一位置和第二位置之间移动并且包括近端(22),远端(24)和在其间延伸的通道(26)。 阀还包括固定体(30),其包括基座(32)和杆(34),当止动器处于第二位置时,杆设置在止动件的通道内。 当止动器处于第一位置时,在通道中存在液密密封,使得流体流过通道被阻止。 止动件移动到第二位置终止液密密封,从而建立通过通道的流体连通。 本文还提供了用于递送重构药物的药物包含装置和组合件。

    CONTINUOUS GLUCOSE MONITORING INJECTION DEVICE

    公开(公告)号:US20190298920A1

    公开(公告)日:2019-10-03

    申请号:US16377048

    申请日:2019-04-05

    Abstract: An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

    NEEDLE ASSEMBLY FOR MIXING OF SUBSTANCES
    8.
    发明申请

    公开(公告)号:US20170340839A1

    公开(公告)日:2017-11-30

    申请号:US15681161

    申请日:2017-08-18

    Abstract: In one aspect of the invention, a needle assembly is provided, including: a body having a proximal end, a distal end, and a channel located therebetween, the body being configured to be mounted to an injector; a needle fixed to the body, the needle having proximal and distal ends, the distal end extending distally from the distal end of the body and being formed for insertion into a patient, the proximal end of the needle being in communication with the channel; and, a filter disposed in the channel proximally of the proximal end of the needle. Advantageously, a needle assembly is provided which permits mixing of at least two substances in preparation for injection, without modification to the associated injector.

Patent Agency Ranking